T1	Participants 1 69	A controlled study of treating haemophilia A on an out-patient basis
T2	Participants 91 226	For six months 36 U factor VIII concentrates per kg bodyweight and week were administered to six out-patients with severe haemophilia A
T3	Participants 228 370	The injection regimen was changed in every patient every two months, from 36 U/kg once to 18 U/kg twice and 12 U/kg three times, intravenously
T4	Participants 376 546	six possible combinations of these three dosage schedules were used in the patients in a strictly randomised manner, and all patients were treated during the same period.
T5	Participants 1118 1232	n addition to freedom from bleeding and no lost days from work, there was increased mobility and physical capacity
